These results provide a preliminary indication that although there are some differences in clinical and histological behavior and markers of BLCA subtypes, PKIB expression, oncogenic role and targets are similar across the major subtypes (basal, luminal, and mixed), indicating the conserved nature of PKIB in BLCA. This evidence concerns the gene PKIB and bladder transitional cell carcinoma.